169 results
Page 5 of 9
S-4
EX-10.22
rdh1a765biazr db40
19 Jul 17
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.20
4b7 muqxv8
19 Jul 17
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.18
5wmvkoo41rqyi9ey
19 Jul 17
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.29
purdt1e
19 Jul 17
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.23
hrj83cq
19 Jul 17
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.33
ee7f6dbyveggoj3a ch
19 Jul 17
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.30
xmv2hmuevj
19 Jul 17
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.31
crjtlfsf
19 Jul 17
Registration of securities issued in business combination transactions
12:00am
8-K
EX-10.1
a4xtea rii9mf
1 Feb 17
Termination of a Material Definitive Agreement
12:00am
8-K
EX-10.1
xxh8jndoybo2ryjkk
25 Mar 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
cs7pt
1 Sep 15
Opexa Secures Private Funding for its NMO Orphan Development Program, Including Planned Phase I/II Clinical Study
12:00am
8-K
EX-10.1
ueedf8gj7y2xjrqf
9 Mar 15
Opexa Amends Agreement with Merck Serono and Receives Additional $3 Million Payment to Support Ongoing Development of Tcelna® for Multiple Sclerosis
12:00am
8-K
EX-10.1
udrgrhf523ey
5 Mar 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
rm8842p0vq0
25 Sep 13
Opexa Announces Conversion of all Convertible Secured Promissory Notes into Common Stock
12:00am